Genetic Testing for RP. Case Study of the UK

Slides:



Advertisements
Similar presentations
This short questionnaire will help to determine whether there may be a gene in your family connected to an increased risk of the development of bowel.
Advertisements

You have to provide a laboratory service for a Caucasian population of 3 million. How would you go about this? Describe your strategy for staff and equipment.
You have recently set up a new disease service in your laboratory. What is the role of the UKGTN? Describe the process involved in submission & evaluation.
The Gene Dossier a Potted History Fiona Stewart. The Start Was not very promising Quite a lot of hostility to the idea that anyone would consider telling.
What Do We Do? Cancer Genetics Service for Wales.
Patients’ Perspective on HTA and Off-label use David Head MBA Chief Executive RP Fighting Blindness 25th Annual EuroMeeting 4-6 March 2013 RAI, Amsterdam.
Department of Ophthalmology, University of British Columbia
Individual Funding Requests Group Work MMS Year 4 Public Health Workshop in O&G.
Obtaining Informed Consent: 1. Elements Of Informed Consent 2. Essential Information For Prospective Participants 3. Obligation for investigators.
Genetic Counseling & Alport Syndrome
EMGO Institute for Health and Care Research Quality of Care Martina Cornel, MD, PhD, professor of Community Genetics & Public Health Genomics PPPC activities.
Jacquie Westwood UK Genetic Testing Network.  Approving UKGTN member labs who provide quality assured tests  Acknowledgment – UKGTN Laboratory Membership.
What is the ACGS? What does the ACGS do? What are the benefits of joining the ACGS? Why should GTs join the ACGS?
Getting Involved in Research: Genetic Counselling Jill Clayton-Smith Central Manchester University Hospitals Foundation Trust.
Provision of Genetic Counselling for Patients with Retinal Dystrophy Prof. Graeme Black, Ms Georgina Hall Depts. of Ophthalmology and Clinical Genetics,
1 Additional Protocol to the Oviedo Convention concerning Genetic Testing for Health Purposes Laurence Lwoff Bioethics Division Council of Europe 6th Meeting.
Guidance Education Support CONNECTIVE TISSUE ONCOLOGY SOCIETY November 2006 SARCOMA ALLIANCE Arthur Beckert Executive Director.
Ethical issues with the regulatory use of gene expression data Benjamin S Wilfond MD Medical Genetics Branch National Human Genome Research Institute Department.
Genome editing: What lessons can we learn from the mitochondrial donation debate? Peter Thompson Human Fertilisation & Embryology Authority.
Retention period(s) of samples/data Many jurisdictions, as well as hospitals and institutions, mandate retention periods for medical or research-related.
Patients’ expectations from genomic applications Nick Meade Director of Policy Genetic Alliance UK Local Networks, Workshop One, 7 th October 2014.
Genes in Life is a place to learn about all the ways genetics is a part of your life. On this site you will learn:   How.
Short Practical examination questions. During your study of clinical psychology you studied a key issue. You also produced a leaflet relating to this.
Healthcare Genetics in the NHS Landscape 1 st Gengage Network Conference June 2009 Dr Mike Winter Medical Director National Services Division.
Shubhangi Arora1; Eden Haverfield2; Gabriele Richard2; Susanne B
Mendelian Genetics Extended (5.2)
What is the ACGS? What does the ACGS do?
Genetics vocabulary.
Background: Need for a national body international development
Usher syndrome By Andy Beer.
Update of the Scientific Secretariat
Midland DHBs Board Development
Annabelle’s Challenge is a UK registered charity with a brave little girl at its heart; eight-year-old Annabelle Griffin. Annabelle was diagnosed with.
Being told you have an Inherited Retinal Dystrophy… and that there is no treatment Tina Houlihan Chief Executive, RP Fighting Blindness.
Challenges and opportunities for professional acupuncturists in the UK
National Healthcare Science Week 2017
Midland DHBs Board Development
Role of keratinized mucosa in peri-implant tissue health.
Why are we contacting you?
Support- IRDiRC Proposed Work Plan And Communication Strategy
On Human Gene Editing: International Summit Statement
Results from a survey of UK patients at risk of bowel cancer, their experiences and information preferences. Selina Goodman, Heather Skirton, Ray Jones.
Family 5.
Ethics in Testing The Placebo Effect.
WHY GENETIC COUNSELING IS IMPORTANT
Genetic Testing Result Means. Before Genetic Testing  The result of genetic testing can be life changing.  It is important for patients and their families.
Parent-Child Relationships
Therapeutic –vs- Reproductive Cloning
Influences.
STEM CELLS and Ethics Sam Roberts PhD student.
Research for all Sharing good practice in research management
AQA GCSE INHERITANCE, VARIATION AND EVOLUTION PART 2
Genomic Medicine Centre Overview
Proposed Maternity, Paternity & Adoption Policy
Specialised Commissioning Improving specialised services for severe intestinal failure adult patients What will this mean for you?
Genomic Medicine Centre Overview
Participants’ Rights Participants of clinical trials have rights, and they are protected under law when participating in clinical trials. The informed.
How we use Your Health Records
NHS Breast Screening Programme
Health and Social Services in the Department of Health
Genomic Medicine Centre Overview
Following Patterns of Inheritance in Humans
Law-making through parliament
Functions of Pressure Groups
Independent Practitioner Chartered Society of Physiotherapy Council
HOW A RETINAL PATIENT GROUP CAN INFLUENCE GENOTYPING IN A DEVELOPING COUNTRY RI Conference , Stresa, 2010.
Fighting blindness: ‘Towards a cure for animals and a cure for humans’
Coproduction of technology and socio-political orders
Six W’s of Genetic Testing
Figure 1: Driver Diagram for QI project.
Presentation transcript:

Genetic Testing for RP. Case Study of the UK Stephen Jones RP Fighting Blindness British Retinitis Pigmentosa Society

Background RP Fighting Blindness has been funding a project to develop genetic tests for RP under Prof Black at Manchester University since 2005 Tests are available for some forms of X-Linked RP and Dominant RP and are being developed for Recessive RP The laboratory in Manchester carries out NHS funded tests and tests for research projects

Why Have Genetic Testing for RP? Better diagnosis and better prognosis of the way RP may develop. Helping ophthalmologists to make better clinical judgements and recommend appropriate genetic counselling. Helping RP patients and families to make important life decisions, for example, pregnancy and career choices Identifying patients for clinical trials

Do RP Patients Want Tests? Research is underway on this subject, preliminary findings indicate: High demand for RP patients to know their own particular gene fault High demand for testing to be available for family members who want a test Lower level of demand for pre-natal testing and pre-implantation selection of embryos

Do Clinicians Want Testing? UK ophthalmologists specialised in RP mostly want access to testing for their patients But, budgets are in the hands of geneticists and not ophthalmologists, so all requests for tests have to be approved by genetics departments

Is Testing Available? Not for all RP patients – some genes not yet found; some genes found but tests not yet developed and approved Even when test exists, approval of request often refused. Reasons – clinical utility and funding Geographic access is patchy. Postcode lottery.

Future Possibilities More research, more tests developed But, less money available within NHS to pay for testing However, cost of testing may fall High throughput gene sequencing Greater availability of private testing but not without concerns Important debate over ethical issues

RPFB Actions Continue scientific research funding Collaborate with social research projects Keep RPFB membership informed through website, newsletters, helpline etc Maintain some pressure on government bodies, such as UK Genetic Testing Network, to improve access to testing for RP patients